A new interactive website, eu.trialstracker.net, shows that 49% of clinical trials on the EU clinical trials register have not reported results. EU rules say clinical trial results must be reported onto the EU register for every trial there within 12 months of the end of the trial. Only 51% of trials on the register are […]
Last year 21 government and philanthropic groups promised to change the way they work. They committed to writing new policy to ensure that all the clinical trials they pay for report their results. This group of funders joined the World Health Organization’s statement on registering and reporting trials and promised to have their new working policy in place within a year. […]
New research shows that most US academic institutions do not have policies to ensure clinical trials run by their researchers are registered and results reported. A survey of 366 universities in the US uncovered that less than half have a policy on registration of clinical trials (43%) and only around a third (35%) have a […]
Most of the world’s largest charities and government bodies who fund clinical trials don’t ask that the results from these trials are reported.
An audit of the stated transparency polices of the 18 philanthropic and public bodies that spend the most money on clinical research has found that most do not require researchers to report results […]
The AllTrials campaign is shining a spotlight on clinical trials that haven’t published results, one per week from now on in the BMJ. Read more about this new series in the BMJ.
The trials we write about will be one of those flagged by the FDAAA Compliance Tracker and, as of 14 September 2018, the EU TrialsTracker […]
I hope you’ve seen our new tool, the FDAAA TrialsTracker, which identifies every individual clinical trial that fails to report its results, live online. Now everyone can see the individual institutes, companies and researchers responsible for unreported trials, the very day they go overdue.
Three weeks ago we highlighted just one of these overdue […]
With the launch of the FDAAA Trials Tracker, we wrote an open letter to the FDA asking them to act on the unreported trials being publically flagged. We’re writing to them every week with the list of trials in breach of the FDAAA Final Rule as well as how much the FDA could have levied […]
Dr Scott Gottlieb
Food and Drug Administration
16th February 2018
Dear Dr Gottlieb
As the body responsible for compliance with the FDA Amendments Act 2007, you have the power to sanction those who break this law, including the levy of fines up to $10,000 a day against clinical trial sponsors who fail to publish their trial results on ClinicalTrials.gov. […]
Síle Lane and Ben Goldacre gave evidence to the House of Commons Science and Technology Committee’s inquiry into research integrity along with Dr Simon Kolstoe.
Watch the session:
Publication bias in clinical trials is the most thoroughly researched aspect of research integrity – having been discussed in detail for over 30 years. And now the area with quite […]
Our review of the world’s largest pharmaceutical companies’ trial registration and reporting policies is now published in the BMJ. This is the first time anyone has systematically examined and compared published company policies on trial transparency.
Most of the largest companies, though not all, have some sort of publicly stated policy about registering and reporting results from current […]